Hypertension and Hypercholesterolemia are Associated with Cataract Development in Patients with Type 2 Diabetes

被引:9
|
作者
Tomic, Martina [1 ]
Vrabec, Romano [1 ]
Rastegorac, Petar [2 ]
Ljubic, Spomenka [3 ,4 ]
Bulum, Tomislav [3 ,4 ]
Rahelic, Dario [3 ,4 ]
机构
[1] Merkur Univ Hosp, Dept Ophthalmol, Vuk Vrhovac Univ Clin Diabet Endocrinol & Metab D, Zagreb, Croatia
[2] Samobor Hlth Ctr, Div Ophthalmol, Samobor, Croatia
[3] Merkur Univ Hosp, Vuk Vrhovac Univ Clin Diabet Endocrinol & Metab D, Dept Diabet & Endocrinol, Dugi Dol 4a, Zagreb 10000, Croatia
[4] Univ Zagreb, Med Sch, Zagreb, Croatia
关键词
Hypertension; Hypercholesterolemia; Cataract; Type; 2; diabetes; BLOOD-PRESSURE; RISK-FACTORS; RETINOPATHY; COMPLICATIONS; POPULATION; PREVALENCE; MELLITUS; MARKERS; PROTEIN;
D O I
10.1007/s40292-021-00472-8
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Introduction Patients with diabetes have up to five times higher incidence of cataract, mainly at a younger age, and cataract in these patients progresses more rapidly than senile cataract, especially in eyes affected with sight-threatening diabetic retinopathy (DR). Aim This study aimed to investigate the risk factors associated with cataract development in patients with type 2 diabetes (T2DM). Methods This case-control cross-sectional study included 90 T2DM (56M/34F). Metabolic risk factors glycated hemoglobin (HbA(1)c), total cholesterol, HDL cholesterol, LDL cholesterol, and triglycerides were determined using routine laboratory methods. Blood pressure was measured with a mercury sphygmomanometer after a 10-min resting period. Lens opacity was graded according to the Lens Opacity Classification System version III (LOCS III). Results According to the LOCS III, patients were divided into two groups: group 1-patients with clear crystalline lens, and group 2-patients with initial cataract. Compared to patients with a clear crystalline lens, those with initial cataract had longer diabetes duration (p = 0.002), higher HbA(1)c (p = 0.037), higher total cholesterol (p = 0.029), higher diastolic blood pressure (DBP) (p = 0.014), and lower creatinine clearance (p = 0.017). Cataract was positively associated with diabetes duration (p = 0.001), HbA(1)c (p = 0.035), LDL cholesterol (p = 0.042), and DBP (p = 0.009), while negatively with creatinine clearance (p = 0.005). Logistic regression analysis showed that the influence of DBP (AOR = 1.06, p = 0.014) and creatinine clearance (AOR = 2.93, p = 0.045) on cataract development remained significant even after adjustment for diabetes duration and HbA(1)c. Conclusions Diabetes duration and various metabolic risk factors, particularly poor glycemic control, hypercholesterolemia, DBP, and diabetic nephropathy's coexistence, are associated with cataract development in T2DM.
引用
收藏
页码:475 / 481
页数:7
相关论文
共 50 条
  • [31] THE USE OF FINDRISC QUESTIONNAIRE IN ASSESSMENT OF RISK OF THE TYPE 2 DIABETES DEVELOPMENT IN PATIENTS WITH HYPERTENSION
    Mastalerz-Migas, A.
    Pokorna-Kalwak, D.
    Sapilak, B.
    ATHEROSCLEROSIS, 2014, 235 (02) : E279 - E279
  • [32] GENETIC POLYMORPHISMS ASSOCIATED WITH THE DEVELOPMENT OF COMORBIDITY OF ESSENTIAL HYPERTENSION AND TYPE 2 DIABETES IN UKRAINIAN POPULATION
    Shalimova, Anna
    Bilovol, Olexander
    Bobronnikova, Lesya
    Prosolenko, Kostyantyn
    JOURNAL OF HYPERTENSION, 2016, 34 : E521 - E522
  • [33] What Characteristics at Baseline Are Associated with the Glucose-Lowering Effect of Colestimide in Patients with Type 2 Diabetes with Hypercholesterolemia?
    Suzuki, Tatsuya
    Watanabe, Kentaro
    Ouchi, Motoshi
    Suzuki, Kazunari
    Sekimizu, Kenichi
    Nakano, Hiroshi
    Oba, Kenzo
    DIABETES, 2011, 60 : A626 - A626
  • [34] REFRACTORY HYPERTENSION, ASSOCIATED AND TYPE 2 DIABETES MELLITUS: DIFFERENCE WITH RESISTANT HYPERTENSION
    Falkovskaya, A.
    Mordovin, V.
    Ripp, T.
    Sitkova, E.
    Zyubanova, I.
    Lichikaki, V.
    Manukyan, M.
    Gusakova, A.
    JOURNAL OF HYPERTENSION, 2018, 36 : E50 - E50
  • [35] Managing hypertension in patients with type 2 diabetes mellitus
    Dobesh, Paul P.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (12) : 1140 - 1149
  • [36] Prevalence of hypertension among patients with type 2 diabetes
    Jadoon, Muhammad Nauman A.
    Shehzad, Muhammad A.
    Yaqoob, Rehan
    ENDOCRINE JOURNAL, 2010, 57 : S565 - S566
  • [37] Exogenous insulin and hypertension in patients with type 2 diabetes
    Lazzari, P.
    Zoppi, A.
    Fogari, R.
    DIABETOLOGIA, 2006, 49 : 635 - 635
  • [38] Management of hypertension in patients with type 2 diabetes mellitus
    Mashitisho, M. L., I
    SOUTH AFRICAN FAMILY PRACTICE, 2013, 55 (01) : 41 - 44
  • [39] Therapy of hypertension in patients with type 2 diabetes mellitus
    Hess, K.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (48) : 2489 - 2492
  • [40] Prevention of microalbuminuria in patients with type 2 diabetes and hypertension
    Menne, Jan
    Izzo, Joseph L., Jr.
    Ito, Sadayoshi
    Januszewicz, Andrzej
    Katayama, Shigehiro
    Chatzykirkou, Christos
    Mimran, Albert
    Rabelink, Ton J.
    Ritz, Eberhard
    Ruilope, Luis M.
    Rump, Lars C.
    Viberti, Giancarlo
    Haller, Hermann
    JOURNAL OF HYPERTENSION, 2012, 30 (04) : 811 - 818